Actively Recruiting
Assessing the Feasibility of Web-based Insomnia Treatment Among Prostate Cancer Survivors
Led by Georgetown University · Updated on 2025-12-05
40
Participants Needed
1
Research Sites
39 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This pilot study will recruit Black/African American prostate cancer survivors into a clinical trial and will randomize each person to 1 of 2 possible treatments - an internet-based treatment for insomnia called Sleep Healthy Using the Internet (SHUTi) or an educational website. SHUTi provides the treatment - cognitive behavioral therapy for insomnia - across 6 lessons, while the educational website is like an online patient brochure. The study will examine the feasibility of SHUTi to improve sleep and well-being among Black prostate cancer survivors. It will also examine whether SHUTi is acceptable to these survivors and will compare the effect of SHUTi versus the educational website on insomnia and non-insomnia patient-reported outcomes.
CONDITIONS
Official Title
Assessing the Feasibility of Web-based Insomnia Treatment Among Prostate Cancer Survivors
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age ≥21 years
- Self-identifies as Black/African American
- Diagnosed with invasive prostate cancer (AJCC stages I-IV) within 5 years
- Has not received surgery, chemotherapy, or radiation within the previous 3 months
- Has a smart phone, tablet, or computer with reliable internet access or willing to attend a weekly study appointment and to complete a weekly phone call
- Has clinically relevant insomnia symptoms (i.e., score ≥10 on the Insomnia Severity Index)
- Able to read and understand English
You will not qualify if you...
- Employed in an occupation where sleep restriction could be a harm to themselves or others
- Actively employed in shift work
- Diagnosed with a severe/major psychiatric disorder
- Diagnosed with a seizure disorder or recently (≤12 months) experienced a seizure
- Unable to consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Georgetown Lombardi Comprehensive Cancer Center
Washington D.C., District of Columbia, United States, 20003
Actively Recruiting
Research Team
T
Traci Bethea
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here